CLGN
NASDAQ · Biotechnology
Collplant Biotechnologies Lt
$0.35
-0.02 (-4.83%)
Open$0.37
Previous Close$0.37
Day High$0.38
Day Low$0.30
52W High$3.23
52W Low$0.27
Volume—
Avg Volume116.2K
Market Cap4.90M
P/E Ratio—
EPS$-1.03
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+4,826.9% upside
Current
$0.35
$0.35
Target
$17.19
$17.19
$14.35
$17.19 avg
$29.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.86M | 1.44M | 1.91M |
| Net Income | -13,865,552 | -6,264,871 | 134.3K |
| Profit Margin | -484.6% | -460.3% | 7.0% |
| EBITDA | -12,756,603 | -6,084,026 | 222.2K |
| Free Cash Flow | — | — | 168.1K |
| Rev Growth | +99.2% | +99.2% | +10.4% |
| Debt/Equity | — | — | 0.39 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |